Treatment of depression in HIV+ men: Literature review and report of an ongoing study of testosterone replacement therapy

Annals of Behavioral Medicine

Volumn 18, Issue 1, 1996, Pages 24-29

  Rabkin, Judith G ^a   Wagner, Glenn ^a   Rabkin, Richard ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD4 ANTIGEN; FLUOXETINE; IMIPRAMINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TESTOSTERONE CIPIONATE; TRICYCLIC ANTIDEPRESSANT AGENT;

ACNE; ANDROGEN THERAPY; APATHY; ARTICLE; CLINICAL TRIAL; DEPRESSION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FATIGUE; HAIR LOSS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOGONADISM; INTRAMUSCULAR DRUG ADMINISTRATION; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MASTALGIA; PHASE 2 CLINICAL TRIAL; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; TENSION; TESTIS ATROPHY; WEIGHT GAIN;

EID: 0029905431     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02903936     Document Type: Article

References (41)

1. Atkinson JH, Grant I: Natural history of neuropsychiatric manifestations of HIV disease. Psychiatric Clinics of North America. 1994, 17:17-34.
2. Williams JBW, Rabkin JG, Remien RH, et al: Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. II. Standardized clinical assessmenr of current and lifetime psychopathology. Archives of General Psychiatry. 1991, 48:124-130.
3. Perkins DO, Stern RA, Golden RN, et al: Mood disorders in HIV infection: Prevalence and risk factors in a nonepicenter of the AIDS epidemic. American Journal of Psychiatry. 1994, 151:233-236.
4. Rosenberger PH, Bornstein RA, Nasrallah HA, et al: Psychopathology in HIV infection: Lifetime and current assessment. Comprehensive Psychiatry. 1993, 34:150-158.
5. Chuang HT, Devins GM, Hunsley J, et al: Psychosocial distress and well-being among gay and bisexual men with HIV infection. American Journal of Psychiatry. 1989, 146:876-880.
6. Chung J, Popkin M, Rhame F, et al: HIV clinic-based study of psychiatric disorders (Abstract NR603). 1995 New Research Program and Abstracts, 146th Annual Meeting, American Psychiatric Association. Washington, DC: American Psychiatric Association, 1993, 211.
7. Perdices M, Dunbar N, Grunseit A, et al: Anxiety, depression, and HIV-related symptomatology across the spectrum of HIV disease. Australian & New Zealand Journal of Psychiatry. 1992, 26:560-566.
8. Rabkin JG, Remien RH, Katoff L, et al: Resilience in adversity among long-term survivors of AIDS. Hospital and Community Psychiatry. 1993, 44:162-167.
9. Robins LN, Regier D: Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York: Free Press, 1991.
10. Lipsitz JD, Williams JBW, Rabkin JG, et al: Psychopathology in male and female intravenous drug users with and without HIV infection. American Journal of Psychiatry, 1994, 151:1662-1668.
11. Joseph JG, Caumartin SM, Tal M, et al: Psychological functioning in a cohort of gay men at risk for AIDS. A three-year descriptive study. Journal of Nervous and Mental Disorders. 1990, 178:607-615.
12. Perry SW, Jacobsberg L, Card C, et al: Severity of psychiatric symptoms after HIV testing. American Journal of Psychiatry. 1993, 150:775-779.
13. Burack J, Barrett D, Stall R, et al: Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. Journal of the American Medical Association. 1993, 270: 2568-2573.
14. Lyketsos C, Hoover D, Guccione M, et al: Depressive symptoms as predictors of medical outcomes in HIV infection. Multicenter AIDS Cohort Study. Journal of the American Medical Association. 1993, 270:2563-2567.
15. Perry SW, Fishman B: Depression and HIV: How does one affect the other? Journal of the American Medical Association. 1993, 270: 2609-2610.
16. Rabkin JG, Rabkin R, Harrison W, Wagner G: Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness. American Journal of Psychiatry. 1994, 151:516-523.
17. MacArthur J, Harrison M: HIV-associated dementia. Current Neurology. 1994, 74:275-320.
18. Stern Y, Marder K, Bell K, et al: Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. III. Neurologic and neuropsychologic findings. Archives of General Psychiatry. 1991, 45:131-138.
19. Manning D, Jacobsberg L, Erhart S, et al: The efficacy of imipramine in the treatment of HIV-related depression. International Conference on AIDS. 1990, 6:141.
20. Rabkin JG, Wagner G, Rabkin R: Sertraline effects on mood and immune status in patients with major depression and HIV illness: An open trial. Journal of Clinical Psychiatry. 1994, 55:433-439.
21. Rabkin JG, Rabkin R, Wagner G: Fluoxetine effects on mood and immune status in depressed patients with HIV illness. Journal of Clinical Psychiatry. 1994, 55:92-97.
22. Levine S, Andersen D, Bystritsky A, et al: Report of eight HIV-seropositive patients with major depression responding to fluoxetine. Journal of Acquired Immune Deficiency Syndromes. 1990, 3:1074-1077.
23. Markowitz J, Rabkin JR, Perry S: Treating depression in HIV+ patients. (Invited Editorial Review). AIDS. 1994, 8:403-412.
24. Kelly JA, Murphy DA, Bahr GR, et al: Outcome of cognitive-behavioral and support group brief therapies for depressed, HIV-infected persons. American Journal of Psychiatry. 1993, 150:1679-1686.
25. Jacobsen FM: Managing sexual dysfunction and SSRIs. Psychiatric Times. 1995, February edition:38-39.
26. Rubin RT: Sex steroid hormone dynamics in endogenous depression: A review. International Journal of Mental Health. 1981, 10: 43-59.
27. Vogel W, Klaiber E, Broverman D: A comparison of the antide-pressant effects of a synthetic androgen (Mesterolone) and amitriptyline in depressed men. Journal of Clinical Psychiatry. 1985, 46:6-8.
28. Luisi M, Franchi F: Double-blind group comparative study of testosterone undecanoate and mesterolone in hypogonadal male patients. Journal of Endocrinological Investigation. 1980, 3:305-308.
29. O'Carroll R, Shapiro C, Bancroft J: Androgens, behavior, and nocturnal erection in hypogonadal men: The effects of varying the replacement dose. Clinical Endocrinology, 1985, 23:527-538.
30. Davidson JM, Cavhargo CA, Smith ER: Effects of androgen on sexual behavior in hypogonadal men. Journal of Endocrinology & Metabolism. 1979, 48:955-958.
31. Salmimies P, Kockett G, Pirk KM: Effects of testosterone replacement on sexual behavior in hypogonadal men. Archives of Sexual Behavior. 1981, 22:345-353.
32. O'Carroll R, Bancroft J: Testosterone therapy for low sexual interest and erectile dysfunction in men: A controlled study. British Journal of Psychiatry. 1984, 145:145-151.
33. Pope HG, Katz DL: Homicide and near-homicide by anabolic steroid users. Journal of Clinical Psychiatry. 1990, 51:28-31.
34. Pope HG, Katz DL: Psychiatric effects of anabolic steroids. Psychiatric Annals. 1992, 22:24-29.
35. Phillips WN: Anabolic Reference Guide (6th Ed.). Golden, CO: Mile High Press, 1991.
36. Cicero TJ, O'Connor LH: Abuse liability of anabolic steroids and their possible role in the abuse of alcohol, morphine, and other substances. In Lin GC, Erinoff L (eds), Anabolic Steroid Abuse (NIDA Monograph #102). DHHS Publication No. (ADM) 90-1720. Washington DC: U.S. Government Printing Office. 1-28.
37. Spitzer RL, Williams JBW, Gibbon M, First M: Structured Clinical Interview for DSM-III-R (SCID). New York: Biometrics Research Division, New York State Psychiatric Institute, 1987.
38. Williams JBW: The Structured Interview Guide for the Hamilton Depression Rating Scale. Archives of General Psychiatry. 1988, 45: 742-747.
39. Derogatis LR, Melisaratos M: The Brief Symptom Inventory: An introductory report. Psychological Medicine. 1983, 13:595-605.
40. Reynolds CF, Frank E, These ME, et al: Assessment of sexual function in depressed, impotent, and healthy men: Factor analysis of a brief sexual function questionnaire for men. Psychiatry Research. 1988, 24:231-250.
41. Endicott J, Nee J, Harrison W, et al: Quality of Life Enjoyment and Satisfaction Questionnaire: A new measure. Psychopharmacology Bulletin. 1993, 29:321-326.